Ischemic stroke, a leading cause of disability and mortality worldwide, is a complex cerebrovascular event with outcomes heavily influenced by the inflammatory response. Read more
Medical News - Nov 21
The Molecular Diagnostics Market is undergoing a major transformation driven by precision medicine, AI-driven pathology, and the global shift toward affordable, rapid, and personalized care. Valued at USD 16.5 billion in 2025, the market is set to reach USD 33.2 Read more
Openpr.com - Nov 17
Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) traded up 7.2% during mid-day trading on Tuesday . The company traded as high as $177.48 and last traded at $179.9120. 94,439 shares were traded during mid-day trading, a decline of 83% from the average session volume of 554,059 sha... Read more
Watch List News - Nov 11
Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report)’s share price rose 7.2% during trading on Tuesday . The company traded as high as $177.48 and last traded at $179.9120. 94,439 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 554,059 sha... Read more
Ticker Report - Nov 11
Publication title: “Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of Life Improvements for Early Alzheimer’s Disease Patients” Read more
Globenewswire_fr - Sep 30
